mifepristone

A federal judge in Texas stayed the FDA's approval of the drug mifepristone, while a federal judge in Washington state blocked any FDA change in access.

Democratic state officials say they're ready to dispense thousands of mifepristone doses if access to the pill becomes difficult as a result of a pending federal lawsuit.

Read the transcript from Wednesday's hearing before Judge Matthew Kacsmaryk in a federal case that could decide the future of access to a major abortion pill.

If the case succeeds, it could have sweeping repercussions — for abortion providers and patients across the nation, as well as for the FDA's drug-approval process.

California Gov. Gavin Newsom said that the state would halt business with Walgreens after the pharmacy giant agreed to stop distributing mifepristone in some red states amid legal pressure.

The drugstore chain’s announcement that access to mifepristone may not expand as broadly as federal regulators intended when they finalized a rule change allowing more pharmacies to provide the pill. Here’s a closer look at the issue.

The suit comes as a federal judge in another case is considering whether to overturn FDA approval of the same drug, mifepristone.

Some abortion providers are looking to misoprostol, a medication widely used around the world, should a federal judge in Texas block access to a key medication abortion option.

Changes by the FDA mean patients won't have to schedule in-person exams to get a prescription. That opens the door for more pharmacies to provide the medication. But not everyone will have access.

Reproductive rights advocates want patients to be allowed to pick up mifepristone at a hospital or clinic. The drug, which was approved 20 years ago, also helps to manage miscarriages for some women.